4//SEC Filing
Gordon David N. 4
Accession 0001209191-21-046683
CIK 0001557746other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 5:32 PM ET
Size
5.3 KB
Accession
0001209191-21-046683
Insider Transaction Report
Form 4
Gordon David N.
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-07-13$16.98/sh−2,631$44,675→ 147,447 total
Footnotes (2)
- [F1]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on July 2, 2021 pursuant to preexisting sell-to-cover elections.
- [F2]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $16.9755 to $17.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001751167
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 5:32 PM ET
- Size
- 5.3 KB